BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9876971)

  • 1. Suppression of gastric acid secretion: preventing excess gas.
    Heard SO
    Intensive Care Med; 1998 Nov; 24(11):1123-5. PubMed ID: 9876971
    [No Abstract]   [Full Text] [Related]  

  • 2. Reliable gastric tonometry after coronary artery surgery: need for acid secretion suppression despite transient failure of acid secretion.
    Bams JL; Kolkman JJ; Roukens MP; Douma DP; Loef BG; Meuwissen SG; Groeneveld AB
    Intensive Care Med; 1998 Nov; 24(11):1139-43. PubMed ID: 9876975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of tissue pH: the critical measurement.
    Fiddian-Green RG
    Chest; 1999 Dec; 116(6):1839-41. PubMed ID: 10593825
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment.
    Johansson KE; Tibbling L
    Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue capnometry as a monitoring strategy for critically ill patients: just about ready for prime time.
    Fink MP
    Chest; 1998 Sep; 114(3):667-70. PubMed ID: 9743146
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastrointestinal PiCO2 monitoring.
    Wall P
    Crit Care Med; 1999 Aug; 27(8):1694-5. PubMed ID: 10470805
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastrointestinal monitoring using measurement of intramucosal PCO2.
    Knichwitz G; Van Aken H; BrĂ¼ssel T
    Anesth Analg; 1998 Jul; 87(1):134-42. PubMed ID: 9661562
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intragastric pH measurement in the critically ill and treatment with parenteral ranitidine.
    Albin M; Friedlos J; Hillman K
    Intensive Care Med; 1985; 11(6):295-9. PubMed ID: 3878851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and variability of gastric pH in critically ill children.
    Gedeit RG; Weigle CG; Havens PL; Werlin SL
    Crit Care Med; 1993 Dec; 21(12):1850-5. PubMed ID: 8252889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the gut to prevent MODS.
    Carroll P
    RN; 1999 Oct; 62(10):34-7; quiz 38. PubMed ID: 10578951
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric intramucosal pH: a noninvasive method for the indirect measurement of tissue oxygenation.
    Clark CH; Gutierrez G
    Am J Crit Care; 1992 Sep; 1(2):53-60. PubMed ID: 1307891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism.
    Chey WD; Woods M; Scheiman JM; Nostrant TT; DelValle J
    Am J Gastroenterol; 1997 Mar; 92(3):446-50. PubMed ID: 9068466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saline tonometry: comparison of Pico2 and pHi values between centers is questionable.
    Thorburn K; Baines PB
    Crit Care Med; 2001 Mar; 29(3):697-8. PubMed ID: 11373449
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
    Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
    Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
    Peghini PL; Katz PO; Castell DO
    Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid secretion from a heterotopic gastric mucosa in the upper esophagus demonstrated by dual probe 24-hour ambulatory pH monitoring.
    Kim EA; Kang DH; Cho HS; Park DK; Kim YK; Park HC; Kim JH
    Korean J Intern Med; 2001 Mar; 16(1):14-7. PubMed ID: 11417299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric secretion in response to a meal 12-13 h after ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1985 Aug; 20(6):711-4. PubMed ID: 3929374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting acid and Helicobacter pylori?
    Healey Z; Calam J
    Gut; 1997 Jul; 41(1):125-6. PubMed ID: 9274484
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ranitidine on gastric acid hypersecretion in an infant with short bowel syndrome.
    Hyman PE; Garvey TQ; Harada T
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):316-9. PubMed ID: 3921686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.